Arbutus Biopharma Corp. (ABUS)

5.055 -0.12 (-2.22%) USD  |  NASDAQ  |  Aug 28, 16:00
5.055 0.00 (0.00%) After-Hours: 18:29
More

Arbutus Biopharma Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
July 28, 2026 --
May 14, 2026 --
April 07, 2026 --
March 04, 2026 --
November 14, 2025 --
September 10, 2025 --
August 11, 2025 --
August 07, 2025 --
August 06, 2025 --
June 25, 2025 --
May 21, 2025 --
May 15, 2025 --
May 14, 2025 --
March 31, 2025 --
March 28, 2025 --
Date Value
March 27, 2025 --
February 26, 2025 --
November 20, 2024 --
November 07, 2024 --
November 06, 2024 --
August 02, 2024 --
August 01, 2024 --
June 07, 2024 --
June 06, 2024 --
June 05, 2024 --
May 03, 2024 --
May 02, 2024 --
March 01, 2024 --
February 29, 2024 --
January 11, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Moderna, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Legend Biotech Corp. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade